Filing Details
- Accession Number:
- 0001209191-18-005565
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-26 16:17:50
- Reporting Period:
- 2018-01-24
- Accepted Time:
- 2018-01-26 16:17:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1180262 | Herbalife Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1311283 | Robert Levy | 800 W. Olympic Boulevard, #406 Los Angeles CA 90015 | Evp, The Americas | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-01-24 | 33,146 | $21.57 | 212,595 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-01-24 | 9,140 | $78.21 | 203,455 | No | 4 | D | Direct | |
Common Stock | Disposition | 2018-01-24 | 10,046 | $78.21 | 193,409 | No | 4 | F | Direct | |
Common Stock | Disposition | 2018-01-26 | 6,980 | $78.54 | 186,429 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2018-01-24 | 33,146 | $0.00 | 33,146 | $21.57 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-02-28 | 2018-02-28 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017.
- The reporting person received 13,960 shares of common stock upon the net exercise of 33,146 stock appreciation rights ("SARS"). The reporting person forfeited 9,140 shares of common stock underlying such SARS in payment of the exercise price and 10,046 shares of common stock underlying such SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on January 24, 2018 of $78.21.